Neurocrine Biosciences, Inc.NBIXNASDAQ
Loading
Total earnings after all expenses, taxes, and interest
3Y CAGR
+45.8%/yr
vs +64.5%/yr prior
5Y CAGR
+3.3%/yr
Recent acceleration
Acceleration
-18.7pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.2x
Modest growth
Streak
4 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $478.60M | +40.2% |
| 2024 | $341.30M | +36.7% |
| 2023 | $249.70M | +61.6% |
| 2022 | $154.50M | +72.4% |
| 2021 | $89.60M | -78.0% |
| 2020 | $407.30M | +1000.8% |
| 2019 | $37.00M | +75.3% |
| 2018 | $21.11M | +114.8% |
| 2017 | $-142.54M | -1.0% |
| 2016 | $-141.09M | - |